Processing

Please wait...

Settings

Settings

Goto Application

1. WO2022094816 - SOLID FORMULATION

Publication Number WO/2022/094816
Publication Date 12.05.2022
International Application No. PCT/CN2020/126596
International Filing Date 04.11.2020
IPC
A61K 9/14 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
A61K 31/404 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403condensed with carbocyclic rings, e.g. carbazole
404Indoles, e.g. pindolol
A61P 31/14 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
Applicants
  • JANSSEN PHARMACEUTICALS, INC. [US]/[US]
  • JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. [CN]/[CN] (SC)
Inventors
  • ZHU, Donghua
  • KIMPE, Kristof Leonard
  • ANDERSEN, Sune
  • RAVELINGIEN, Matthieu Jean M
  • SOMERS, Ivan Henri M
Agents
  • NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD.
Priority Data
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) SOLID FORMULATION
(FR) FORMULATION SOLIDE
Abstract
(EN) Provided are pharmaceutical formulations comprising an active pharmaceutical ingredient; and one of methacrylic acid copolymer, or hydroxypropyl methylcellulose wherein the active pharmaceutical ingredient is a dengue viral replication inhibitor. Solid dosage forms comprising said pharmaceutical formulations, processes for preparing these and their use in methods of prevention and/or treatment are also described.
(FR) L'invention concerne des formulations pharmaceutiques comprenant un principe pharmaceutique actif ; et un élément parmi le copolymère d'acide méthacrylique ou l'hydroxypropylméthylcellulose, le principe pharmaceutique actif étant un inhibiteur de réplication du virus de la dengue. L'invention concerne également des formes posologiques solides comprenant lesdites formulations pharmaceutiques, des procédés pour leur préparation et leur utilisation dans des procédés de prévention et/ou de traitement.
Latest bibliographic data on file with the International Bureau